Antibiotics for Tuberculosis

Treats 15 Patients

Antibiotics for Tuberculosis

Over 11 million people across the world are affected by tuberculosis (TB). And while many people infected with tuberculosis will never have any symptoms, 10% will develop active TB at some point in their lives. It’s a disease that causes extreme suffering and death, but it is curable with long-term treatment.

In 2010, MSF admitted 30,090 people for TB treatment. Patients receive an initial treatment of a combination of antibiotic drugs (isoniazid, rifampicin, pyrazinamide and ethambutol) over a period of 2 months. These drugs, developed over 50 years ago, remain the only available ones on the world market to treat tuberculosis, a neglected disease. While MSF treats people with tuberculosis worldwide, the disease is especially pervasive in Malawi, Mozambique, the Russian Federation, Swaziland and Zimbabwe.

Purchase a symbolic gift now and provide medical care to help people in need!

You have attempted to leave this page. If you have made any changes to the fields without clicking the submit button, your changes will be lost. Are you sure you want to exit this page?